Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Baxter
McKesson
Dow
Harvard Business School

Last Updated: November 16, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for SIMCOR

See Plans and Pricing

« Back to Dashboard

Drug Sales Revenue Trends for SIMCOR
Drug Units Sold Trends for SIMCOR

Annual Sales Revenues and Units Sold for SIMCOR

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
SIMCOR   Start Trial   Start Trial 2017
SIMCOR   Start Trial   Start Trial 2016
SIMCOR   Start Trial   Start Trial 2015
SIMCOR   Start Trial   Start Trial 2014
SIMCOR   Start Trial   Start Trial 2013
SIMCOR   Start Trial   Start Trial 2012
SIMCOR   Start Trial   Start Trial 2011
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Express Scripts
Baxter
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.